I Wasn't Sleeping Badly — But I Knew I Wasn't Sleeping Well Either
There's a version of sleep where you log eight hours, wake up, and still feel like you've been dragged through something. No obvious problem — you're not lying awake at 3am, you're not waking constantly — but the recovery just isn't there. That was me for a long time. I'd train consistently, eat well, manage stress reasonably well by most standards, and still find myself wondering why I wasn't feeling the benefit of it all. Recovery was the missing piece, and I wasn't willing to just accept it as "getting older" at 35. That's what led me down the research rabbit hole on ipamorelin — and eventually to running it myself for research purposes.
Why I Started Researching This
I'm the founder of No Nonsense Fitness and Nutrition, and before I'd ever list something on irishpeptides.ie I want to understand it properly myself. That means reading, understanding the mechanism, understanding the risk profile, and where it makes sense — observing it firsthand. With ipamorelin, what caught my attention early was the specificity. It's a growth hormone secretagogue — it stimulates the pituitary to release GH — but unlike some older compounds, it does this without meaningfully spiking cortisol or prolactin. That selectivity matters to me. I'm not interested in blunt instruments.
In Ireland, the conversation around peptides is still relatively early compared to the US or Australia. Most people here are either in the fitness world and have vague awareness of these compounds, or they've never heard of them at all. What I wanted to do was understand this properly so I could speak to an Irish audience honestly — not with hype, not with marketing language, but with real context.
The sleep angle was what really focused my interest. GH release follows a circadian pattern — the largest pulses happen during deep slow-wave sleep, particularly in the first few hours of the night. If ipamorelin was genuinely amplifying those pulses at a physiologically meaningful time, the downstream effects on recovery could be significant. That was worth researching further.
What the Research Actually Says
Ipamorelin is a pentapeptide — five amino acids — that works as a selective ghrelin receptor agonist. Research suggests it stimulates pulsatile GH release in a way that mimics the body's natural secretion pattern more closely than synthetic GH administration. Studies indicate that because it works through the pituitary rather than bypassing it entirely, it may preserve the feedback mechanisms that prevent excess GH accumulation — which is part of why pituitary sensitivity is a relevant consideration for anyone researching longer-term protocols.
There's a well-established rationale in the research literature for pairing ipamorelin with a GHRH analogue — I use CJC-1295 no DAC alongside it. CJC-1295 no DAC (as opposed to the DAC version) has a shorter half-life and works synergistically with ipamorelin: the GHRH component amplifies the pituitary's response, while ipamorelin provides the direct secretagogue stimulus. Research suggests the combination produces a more robust GH pulse than either compound alone. The timing matters too — administering before sleep, when the body is already primed for its largest natural GH release, is the approach most commonly referenced in research contexts.
On the question of pituitary sensitivity, research suggests that continuous stimulation without adequate recovery periods can blunt the pituitary's response over time. This is a reason why structured protocols with defined off-days appear in the research literature, rather than daily administration indefinitely.
My Personal Experience
My current protocol, for research purposes, is 200mcg of ipamorelin five days per week — Tuesday, Wednesday, Thursday, Friday, and Sunday. Monday and Saturday are off days. The 5-on/2-off structure is intentional: the rationale is to preserve pituitary sensitivity by building in regular rest from stimulation. I pair it with CJC-1295 no DAC at the same time, administered subcutaneously before sleep.
The first thing I noticed — and this happened within the first week — was sleep quality. I track sleep on my watch and pay attention to slow-wave sleep specifically. Within that first week, my deep sleep metrics showed a measurable change. Not dramatic on the charts, but consistent and clearly different from my baseline. That was the moment I thought: something is actually happening here. It wasn't a placebo effect I was chasing — I wasn't expecting results that quickly, and I wasn't monitoring the data obsessively. I happened to check at the end of the week and the numbers were different.
Beyond the tracking data, the subjective experience of sleep changed. I was waking up feeling more restored. Not dramatically, not overnight — but over three or four weeks it became something I could describe to someone else. The kind of sleep where you actually feel like you've recovered. Training sessions earlier in the week felt better later in the week. That could be multiple factors — I'm not claiming ipamorelin alone caused any of it — but the timing was consistent with when I introduced the protocol.
What I didn't experience: hunger spikes beyond normal, cortisol-type symptoms, water retention, anything that interrupted day-to-day function. The selectivity of ipamorelin seems to hold up in practice, in my experience at least.
What I'd Tell Someone Considering This
First: bloodwork before anything. Get a baseline. Fasting GH, IGF-1, full hormonal panel if you can access it. In Ireland, this isn't as straightforward as it might be in other countries — private testing is the practical route for most people — but it's not optional if you're going to do this properly. You need to know where you're starting from.
Second: peptides are for research purposes. I'm not a doctor, nothing here is medical advice, and ipamorelin is not licensed as a medicine in Ireland. If you're considering this, that's the framework you're operating in.
Third: start conservative. 100mcg is a sensible starting point for observation before considering 200mcg. Track everything — sleep, subjective recovery, training performance, whatever is relevant to your goals. Anecdotal data from your own body, tracked consistently over time, is actually useful information.
Fourth: the 5-on/2-off structure exists for a reason. If the rationale for off-days is preserving pituitary sensitivity, then skipping the off-days undermines the protocol. Discipline in the structure matters as much as the compound itself.
Finally: pair your research with realistic expectations. In my experience, the effects of ipamorelin are measurable but not dramatic in the short term. If you're expecting to feel transformed in 48 hours, you'll miss what's actually happening. Track over weeks, not days.
Summary
Ipamorelin is one of the more interesting peptides I've researched and run personally, specifically because of its selectivity and its relevance to sleep and recovery — two things that matter enormously to anyone training seriously. My own protocol of 200mcg five days per week, paired with CJC-1295 no DAC before sleep, produced measurable changes in my deep sleep tracking within the first week and noticeable improvements in subjective recovery over the following weeks. I'm not making claims about what it will do for anyone else — individual responses vary, and context matters. But for anyone curious about this area and willing to approach it properly, it's worth researching.
If you're based in Ireland and want to explore the research further, the free tools and resources at irishpeptides.ie/free-tools are a good starting point — dosing calculators, cycle planners, and research references built specifically for an Irish audience.